IMC Chicago’s AbbVie ABBV Stock Holding History

IMC Chicago’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-91,287	Closed	-$20.2M	–	5675
2025 Q4	$20.9M	Buy	+91,287	New	+$20.8M	0.01%	830
2025 Q3	–	Sell	-38,946	Closed	-$7.93M	–	3557
2025 Q2	$7.23M	Buy	38,946 +7,876	+25%	+$1.46M	﹤0.01%	1186
2025 Q1	$6.51M	Sell	31,070 -28,577	-48%	-$5.56M	﹤0.01%	1083
2024 Q4	$10.6M	Buy	59,647 +20,272	+51%	+$3.73M	﹤0.01%	887
2024 Q3	$7.78M	Buy	+39,375	New	+$7.35M	﹤0.01%	932
2023 Q4	–	Sell	-12,932	Closed	-$1.89M	–	1796
2023 Q3	$1.93M	Buy	+12,932	New	+$1.9M	﹤0.01%	999
2022 Q4	–	Sell	-15,843	Closed	-$2.43M	–	1245
2022 Q3	$2.13M	Buy	+15,843	New	+$2.27M	﹤0.01%	740
2020 Q4	–	Sell	-18,333	Closed	-$1.76M	–	1032
2020 Q3	$1.61M	Sell	18,333 -12,510	-41%	-$1.18M	﹤0.01%	629
2020 Q2	$3.03M	Buy	+30,843	New	+$2.72M	0.01%	469
2020 Q1	–	Sell	-26,745	Closed	-$2.28M	–	825
2019 Q4	$2.37M	Buy	+26,745	New	+$2.22M	0.01%	487

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

IMC Chicago's ABBV Position: Q1 2026 in Review

IMC Chicago sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 91,287 shares — an estimated $20.2M sold.

IMC Chicago first reported a position in ABBV in Q4 2019 and held it in 10 quarters. The position peaked at $20.9M in Q4 2025. 4,097 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

IMC Chicago reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
IMC Chicago sold 91,287 AbbVie shares in Q1 2026, an estimated $20.2M.
IMC Chicago first reported a position in AbbVie in Q4 2019 and held it in 10 quarters.
IMC Chicago's AbbVie position peaked at $20.9M in Q4 2025.
4,097 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.